Table 4 Mean relative change of Reserve group antibiotics
Antibiotics | Route | DDD/100-BD per Year | Mean Relative Change (%) (2017–2021) | ||||
|---|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 | 2021 | |||
Colistimethate Sodium* | IV | 0.22 | 3.145 | 4.014 | 4.613 | 5.018 | |
Relative Change | 1322.647 | 1715.794 | 1986.672 | 2169.7 | 1798.708 | ||
Fosfomycin | IV | 0.475 | 0.376 | 0.496 | 0.596 | 0.344 | |
Relative Change | -20.861 | 4.437 | 25.508 | -27.71 | -4.657 | ||
Linezolid | IV | 1.34 | 1.9100 | 1.930 | 1.88 | 2.140 | |
Relative Change | 3.607 | -4.454 | 40.391 | -94.96 | 46.713 | ||
Linezolid | Oral | 0.802 | 0.967 | 0.921 | 1.173 | 1.366 | |
Relative Change | 20.546 | 14.833 | 46.249 | 70.285 | 37.978 | ||
Tigecycline | IV | 0.550 | 0.458 | 0.514 | 0.513 | 0.322 | |
Relative Change | -16.796 | -6.473 | -6.731 | -41.53 | -17.884 | ||